Dose-Dependent Pharmacokinetics of Amphotericin B Lipid Complex in Rabbits

Amphotericin B lipid complex (ABLC) was recently approved by the Food and Drug Administration for treatment of patients with invasive fungal infections who are intolerant of or refractory to conventional amphotericin B therapy. Little is known, however, about the pharmacokinetics of this new antifun...

Disgrifiad llawn

Manylion Llyfryddiaeth

Cyhoeddwyd yn:	Antimicrob Agents Chemother
Prif Awduron:	Walsh, Thomas J., Jackson, Andre J., Lee, James W., Amantea, Michael, Sein, Tin, Bacher, John, Zech, Loren
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	American Society for Microbiology (ASM) 2000
Pynciau:	Pharmacology
Mynediad Ar-lein:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90015/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10898677/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.8.2068-2076.2000
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!